These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 15236403)
1. Prevention of neuropathology in the mouse model of Hurler syndrome. Desmaris N; Verot L; Puech JP; Caillaud C; Vanier MT; Heard JM Ann Neurol; 2004 Jul; 56(1):68-76. PubMed ID: 15236403 [TBL] [Abstract][Full Text] [Related]
2. Intrathecal administration of AAV vectors for the treatment of lysosomal storage in the brains of MPS I mice. Watson G; Bastacky J; Belichenko P; Buddhikot M; Jungles S; Vellard M; Mobley WC; Kakkis E Gene Ther; 2006 Jun; 13(11):917-25. PubMed ID: 16482204 [TBL] [Abstract][Full Text] [Related]
3. Gene therapy of the brain in the dog model of Hurler's syndrome. Ciron C; Desmaris N; Colle MA; Raoul S; Joussemet B; Vérot L; Ausseil J; Froissart R; Roux F; Chérel Y; Ferry N; Lajat Y; Schwartz B; Vanier MT; Maire I; Tardieu M; Moullier P; Heard JM Ann Neurol; 2006 Aug; 60(2):204-13. PubMed ID: 16718701 [TBL] [Abstract][Full Text] [Related]
4. Retrovirus-mediated transfer of the human alpha-L-iduronidase cDNA into human hematopoietic progenitor cells leads to correction in trans of Hurler fibroblasts. Huang MM; Wong A; Yu X; Kakkis E; Kohn DB Gene Ther; 1997 Nov; 4(11):1150-9. PubMed ID: 9425437 [TBL] [Abstract][Full Text] [Related]
5. alpha-L-Iduronidase transport in neurites. Chen F; Vitry S; Hocquemiller M; Desmaris N; Ausseil J; Heard JM Mol Genet Metab; 2006 Apr; 87(4):349-58. PubMed ID: 16439176 [TBL] [Abstract][Full Text] [Related]
6. Neonatal gene therapy of MPS I mice by intravenous injection of a lentiviral vector. Kobayashi H; Carbonaro D; Pepper K; Petersen D; Ge S; Jackson H; Shimada H; Moats R; Kohn DB Mol Ther; 2005 May; 11(5):776-89. PubMed ID: 15851016 [TBL] [Abstract][Full Text] [Related]
7. Effect of neonatal administration of a retroviral vector expressing alpha-L-iduronidase upon lysosomal storage in brain and other organs in mucopolysaccharidosis I mice. Chung S; Ma X; Liu Y; Lee D; Tittiger M; Ponder KP Mol Genet Metab; 2007 Feb; 90(2):181-92. PubMed ID: 16979922 [TBL] [Abstract][Full Text] [Related]
8. Intranasal Adeno-Associated Virus Mediated Gene Delivery and Expression of Human Iduronidase in the Central Nervous System: A Noninvasive and Effective Approach for Prevention of Neurologic Disease in Mucopolysaccharidosis Type I. Belur LR; Temme A; Podetz-Pedersen KM; Riedl M; Vulchanova L; Robinson N; Hanson LR; Kozarsky KF; Orchard PJ; Frey WH; Low WC; McIvor RS Hum Gene Ther; 2017 Jul; 28(7):576-587. PubMed ID: 28462595 [TBL] [Abstract][Full Text] [Related]
9. α- L-iduronidase gene-based therapy using the phiC31 system to treat mucopolysaccharidose type I mice. Stilhano RS; Martin PK; de Melo SM; Samoto VY; Peres GB; da Silva Michelacci YM; da Silva FH; Pereira VG; D'Almeida V; da Cruz AT; Jasiulionis MG; Han SW J Gene Med; 2015; 17(1-2):1-13. PubMed ID: 25597593 [TBL] [Abstract][Full Text] [Related]
10. Correction of metabolic, craniofacial, and neurologic abnormalities in MPS I mice treated at birth with adeno-associated virus vector transducing the human alpha-L-iduronidase gene. Hartung SD; Frandsen JL; Pan D; Koniar BL; Graupman P; Gunther R; Low WC; Whitley CB; McIvor RS Mol Ther; 2004 Jun; 9(6):866-75. PubMed ID: 15194053 [TBL] [Abstract][Full Text] [Related]
11. Reversal of lysosomal storage in brain of adult MPS-I mice with intravenous Trojan horse-iduronidase fusion protein. Boado RJ; Hui EK; Lu JZ; Zhou QH; Pardridge WM Mol Pharm; 2011 Aug; 8(4):1342-50. PubMed ID: 21667973 [TBL] [Abstract][Full Text] [Related]
12. Comparison of Endovascular and Intraventricular Gene Therapy With Adeno-Associated Virus-α-L-Iduronidase for Hurler Disease. Janson CG; Romanova LG; Leone P; Nan Z; Belur L; McIvor RS; Low WC Neurosurgery; 2014 Jan; 74(1):99-111. PubMed ID: 24077583 [TBL] [Abstract][Full Text] [Related]
13. Improved behavior and neuropathology in the mouse model of Sanfilippo type IIIB disease after adeno-associated virus-mediated gene transfer in the striatum. Cressant A; Desmaris N; Verot L; Bréjot T; Froissart R; Vanier MT; Maire I; Heard JM J Neurosci; 2004 Nov; 24(45):10229-39. PubMed ID: 15537895 [TBL] [Abstract][Full Text] [Related]
14. Partial cure of established disease in an animal model of metachromatic leukodystrophy after intracerebral adeno-associated virus-mediated gene transfer. Sevin C; Verot L; Benraiss A; Van Dam D; Bonnin D; Nagels G; Fouquet F; Gieselmann V; Vanier MT; De Deyn PP; Aubourg P; Cartier N Gene Ther; 2007 Mar; 14(5):405-14. PubMed ID: 17093507 [TBL] [Abstract][Full Text] [Related]
15. Prediction of neuropathology in mucopolysaccharidosis I patients. Fuller M; Brooks DA; Evangelista M; Hein LK; Hopwood JJ; Meikle PJ Mol Genet Metab; 2005 Jan; 84(1):18-24. PubMed ID: 15639191 [TBL] [Abstract][Full Text] [Related]
16. Long-term and significant correction of brain lesions in adult mucopolysaccharidosis type VII mice using recombinant AAV vectors. Bosch A; Perret E; Desmaris N; Heard JM Mol Ther; 2000 Jan; 1(1):63-70. PubMed ID: 10933913 [TBL] [Abstract][Full Text] [Related]
17. Intracranial injection of recombinant adeno-associated virus improves cognitive function in a murine model of mucopolysaccharidosis type VII. Frisella WA; O'Connor LH; Vogler CA; Roberts M; Walkley S; Levy B; Daly TM; Sands MS Mol Ther; 2001 Mar; 3(3):351-8. PubMed ID: 11273777 [TBL] [Abstract][Full Text] [Related]
18. Encapsulated engineered myoblasts can cure Hurler syndrome: preclinical experiments in the mouse model. Piller Puicher E; Tomanin R; Salvalaio M; Friso A; Hortelano G; Marin O; Scarpa M Gene Ther; 2012 Apr; 19(4):355-64. PubMed ID: 21716300 [TBL] [Abstract][Full Text] [Related]
19. Genetic correction of the fetal brain increases the lifespan of mice with the severe multisystemic disease mucopolysaccharidosis type VII. Karolewski BA; Wolfe JH Mol Ther; 2006 Jul; 14(1):14-24. PubMed ID: 16624622 [TBL] [Abstract][Full Text] [Related]
20. [Construction of an adenoassociated, viral derived, expression vector to correct the genetic defect in Morquio A disease]. Gutiérrez MA; García-Vallejo F; Tomatsu S; Cerón F; Alméciga-Díaz CJ; Domínguez MC; Barrera LA Biomedica; 2008 Sep; 28(3):448-59. PubMed ID: 19034368 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]